First, we have analyzed in cfDNA from eight mPDAC patients the methylation levels of five genes BMP3, NPTX2, SPARC, TFPI2 and SFRP1 known to be aberrantly methylated in pancreatic cancer. This evidence concerns the gene NPTX2 and pancreatic neoplasm.